Our products are intended for research and investigative use only. They are not for human consumption, clinical or therapeutic use, and are not intended to diagnose, treat, cure, or prevent any disease.
PT-141 (Bremelanotide)
Dual GIP/GLP-1 receptor agonist for advanced metabolic research. This novel compound enables studies in dual-incretin pathways and their effects on metabolic function.
$34.99
Research-grade purity
Third-party tested
Lyophilized powder
Sterile filtered
Dual GIP/GLP-1 receptor agonist for advanced metabolic research. This novel compound enables studies in dual-incretin pathways and their effects on metabolic function. Our products undergo rigorous quality control and are manufactured under strict laboratory conditions to ensure the highest standards for research applications.
CAS Number
189691-06-3
PubChem CID
9941379
Molecular Weight
1025.2 g/mol
Molecular Formula
C50H68N14O10
Synonyms
Bremelanotide, PT-141, PT 141 (free base; CAS 189691-06-3; commonly sold as the acetate salt, separate CAS 1607799-13-2, formula C52H72N14O12, MW ~1085.2 g/mol)
Amino Acid Sequence
Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-OH; N-acetylated cyclic heptapeptide, ring closed by a lactam (amide) bridge between the Asp side-chain carboxyl and the Lys side-chain amine (contains D-Phe and Nle/norleucine)
Appearance
Lyophilized white to off-white powder
Storage Conditions
Store lyophilized powder at -20°C, protected from light and moisture; once reconstituted, store at 2-8°C and use within 2-4 weeks (for longer storage, aliquot and keep at -20°C, avoiding repeated freeze-thaw cycles).
Lab results not available.




